Atypical squamous cells of undetermined significance: A cytohistological study in a colposcopy clinic

Diagnostic Cytopathology

Volumn 21, Issue 3, 1999, Pages 211-216

  Ettler, Helen C ^a,b   Joseph, Mariamma G ^a   Downing, Patricia A ^a   Suskin, Neville G ^a   Wright, V Cecil ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

ASCUS; Bethesda system; Pap smear; Squamous atypia; Squamous intraepithelial lesion

Indexed keywords

ARTICLE; CELL NUCLEUS MEMBRANE; COLPOSCOPY; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; EPITHELIUM DYSPLASIA; FEMALE; FEMALE GENITAL TRACT CYTOLOGY; HUMAN; HUMAN TISSUE; PAPANICOLAOU TEST; PRIORITY JOURNAL; SQUAMOUS CELL; UTERINE CERVIX BIOPSY;

BIOPSY; CERVIX UTERI; COLPOSCOPY; EPITHELIAL CELLS; FEMALE; HUMANS; LOGISTIC MODELS; NUCLEAR ENVELOPE; OBSERVER VARIATION; UTERINE CERVICAL DYSPLASIA; VAGINAL SMEARS;

EID: 0032787218     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0339(199909)21:3<211::AID-DC14>3.0.CO;2-S     Document Type: Article

References (30)

1. National Cancer Institute Workshop. The 1988 Bethesda system for reporting cervical/vaginal diagnoses. JAMA 1989;262:931-934.
2. The revised Bethesda system for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda Workshop. Acta Cytol 1992;36: 273-276.
3. Noumoff JS. Atypia in cervical cytology as a risk factor for intraepithelial neoplasia. Am J Obstet Gynecol 1987;156:628-631.
4. Darnell Jones DE, Creasman WT, Dombrowski RA, Lentz SS, Waeltz JL. Evaluation of the atypical Pap smear. Am J Obstet Gynecol 1987;157:544-549.
5. Slawson DC, Bennett JH, Herman JM. Follow-up Papanicolaou smear for cervical atypia: are we missing significant disease? J Fam Pract 1993;36:289-293.
6. Kohan S, Noumoff J, Beckman EM, Morris M, Weiner E, Douglas GW. Colposcopic screening of women with atypical Papanicolaou smears. J Reprod Med 1985;30:383-387.
7. Reiter RC. Management of initial atypical cytology: a randomized, prospective study. Obstet Gynecol 1986;68:237-240.
8. Kline MJ, Davey DD. Atypical squamous cells of undetermined significance qualified: a follow-up study. Diagn Cytopathol 1996;14: 380-384.
9. Maier RC, Schultenover SJ. Evaluation of the atypical squamous cell Papanicolaou smear. Int J Gynecol Pathol 1986;5:242-248.
10. Lindheim SR, Smith-Nguyen G. Aggressive evaluation for atypical cells in Papanicolaou smears. J Reprod Med 1990;35:971-973.
11. Morrison BW, Erickson ER, Doshi N, Russo JR. The significance of atypical cervical smears. J Reprod Med 1988;33:809-812.
12. Davis GL, Hernandez E, Davis JL, Miyazawa K. Atypical squamous cells in Papanicolaou smears. Obstet Gynecol 1987;69:43-46.
13. Howell LP, Davis RL. Follow-up of Papanicolaou smears diagnosed as atypical squamous cells of undetermined significance. Diagn Cytopathol 1996;14:20-24.
14. Andrews S, Hernandez E, Miyazawa K. Paired Papanicolaou smears in the evaluation of atypical squamous cells. Obstet Gynecol 1989;73:747-750.
15. Sidway MK, Tabbara SO. Reactive change and atypical squamous cells of undetermined significance in Papanicolaou smears: a cytohistologic correlation. Diagn Cytopathol 1993;9:423-429.
16. Collins LC, Wang HH, Abu-Jawdeh GM. Qualifiers of atypical squamous cells of undetermined significance help in patient management. Mod Pathol 1996;9:677-681.
17. Genest D, Galvanek E, Lee K, La Guette J, Sheets E, Crum C, Cibas E. Subclassification of atypical Pap smears and the likelihood of squamous intraepithehal lesion (SIL) on subsequent biopsy. Mod Pathol 1996;9:34.
18. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. Boston, Toronto, and London: Little, Brown and Company; 1991:119-120.
19. Fleiss JL. The design and analysis of clinical experiments. New York: John Wiley & Sons; 1986:1-32.
20. Davey DD, Naryshkin S, Nielsen ML, Kline TS. Atypical squamous cells of undetermined significance: interlaboratory comparison and quality assurance monitors. Diagn Cytopathol 1994;11:390-396.
21. Abu-Jawdeh GM, Trawinski G, Wang HH. Histocytological study of squamous atypia on Pap smears. Mod Pathol 1994;7:920-924.
22. Chhieng DC, Taylor J, Schmee J, McKenna BJ. Interobserver variation in reporting cervicovaginal smears with low grade squamous cell abnormalities. Mod Pathol 1997;10:32.
23. Sherman ME, Schiffman H, Lorincz AT, Manos MM, Scott DR, Kurman RJ, Kiviat NB, Stoler M, Glass AG, Rush BB. Toward objective quality assurance in cervical cytopathology. Am J Clin Pathol 1994;102:182-187.
24. Joste NE, Rushing L, Granados R, Zitz JC, Genest DR, Crum CP, Cibar ES. Bethesda classification of cervicovaginal smears: reproducibility and viral correlates. Hum Pathol 1996;27:581-585.
25. Lee KR, Minier LJ, Crum CP. Koilocytic atypia in Papanicolaou smears: reproducibility and biopsy correlations. Cancer (Cancer Cytopathol) 1997;81:10-15.
26. McCluggage WG, Bharucha H, Caughley, LM, Date A, Hamilton, PW, Thornton CM, Walsh MY. Interobserver variation in the reporting of cervical biopsy specimens: comparison of grading systems. J Clin Pathol 1996;49:833-835.
27. Young NA, Naryshkin S, Bowman RL. Value of repeat cervical smears at the time of colposcopic biopsy. Diagn Cytopathol 1993;9-646-649.
28. Koss LG. The Papanicolaou test for cervical cancer detection: a triumph and a tragedy. JAMA 1989;261:737-743.
29. Jones BA, Novis DA. Cervical biopsy-cytology correlation: a College of American Pathologists Q-Probes study of 22,439 correlations in 348 laboratories. Arch Pathol Lab Med 1996;120:523-531.
30. Kurrman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH. Interim guidelines for the management of abnormal cervical cytology. JAMA 1994;271:1866-1869.